Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Clasificación en acciones #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Precio por acción
$25.28
Última sincronización: 2026-09-18
Capitalización bursátil
$1.01B
Cambio (1 día)
-2.29%
Cambio (1 año)
-37.84%
País
GB
Comercio GSK plc (GSK)

Categoría

Ratio P/E de GSK plc (GSK)
Ratio P/E al September 2026 TTM: 15.45
Según los últimos informes financieros y el precio de las acciones de GSK plc, el P/E actual (TTM) de la empresa es 15.45. Al final de 2024, la empresa tenía un P/E de 21.32.
Historial del ratio P/E de GSK plc desde 2000 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 15.45 19.52%
2025 12.93 -39.35%
2024 21.32 78.79%
2023 11.92 208.12%
2022 3.87 -67.35%
2021 11.85 26.27%
2020 9.39 -38.69%
2019 15.31 -6.32%
2018 16.34 -52.05%
2017 34.08 -49.33%
2016 67.26 956.89%
2015 6.36 -67.19%
2014 19.40 67.62%
2013 11.57 -1.74%
2012 11.78 3.64%
2011 11.36 -63.56%
2010 31.18 219.11%
2009 9.77 -16.60%
2008 11.72 7.01%
2007 10.95 -5.13%
2006 11.54 -19.65%
2005 14.36 -0.89%
2004 14.49 8.99%
2003 13.30 -8.11%
2002 14.47 -46.94%
2001 27.27 22.42%
2000 22.28 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
38.12 146.64%
US
30.79 99.22%
US
73.73 377.08%
US
22.25 43.96%
CH
114.95 643.83%
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.